AI brief of an SEC Form 8-K · Omega Healthcare Investors (OHI)

Omega Healthcare raises 2024 AFFO guidance to $2.78-$2.84 per share after Q2 gains

Positive Impact 4 of 5 earnings Written later

Omega Healthcare Investors reported second-quarter 2024 net income of $117 million, or $0.45 per diluted share, up from $62 million, or $0.25, a year earlier, and raised its full-year 2024 Adjusted FFO guidance to $2.78 to $2.84 per share from $2.70 to $2.80. Quarterly Adjusted FFO per share was $0.71, down from $0.74 in the second quarter of 2023.

Key points

  • Q2 2024 net income was $117 million ($0.45 diluted per share), versus $62 million ($0.25) in Q2 2023.
  • Q2 2024 Adjusted FFO was $185 million ($0.71 per share), versus $183 million ($0.74) in Q2 2023.
  • Total revenues were $252.7 million, up from $250.2 million in Q2 2023.
  • The company completed $648 million in new investments through July 31, 2024, and LaVie Care Centers filed for Chapter 11 bankruptcy protection in June 2024.

The filing

CompanyOmega Healthcare Investors (OHI)
Form8-K, current report
Filed with the SECAug 1, 2024, 4:21 PM ET
Accession number0000888491-24-000034

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 01, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.